Debates & Insight Sponsored Available on demand: Disrupting and improving customer engag... There are clear benefits for both Life Sciences companies and their customers in significantly improving the way they engage.
Debates & Insight Sponsored Available on demand: Customer data is the lifeblood of comme... Findings from the Veeva 2015 European Life Sciences Survey
News J&J scores EU approval for Tecvayli combo in second line Johnson & Johnson's multiple myeloma regimen is now approved as a second line treatment in both the US and the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
